Physician profile
Maxime G Gedeon
NPI 1720074487
$1,677.44
in general payments reported to CMS, 2019-2025
8 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.92 · 2020: $59.59 · 2024: $148 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,115 · Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,115.31 |
| Food and Beverage | $480.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $1,279.43 | 2024-2025 | Sprint Pns System |
| Curonix LLC | $119.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $85.29 | 2020-2025 | General - Pain Management |
| Averitas Pharma INC. | $74.74 | 2025 | Qutenza |
| Medtronic, INC. | $50.05 | 2025 | Inceptiv |
| Protega Pharmaceutials INC | $29.44 | 2025 | Roxybond |
| Medtronic USA, INC. | $21.92 | 2019 | |
| Saluda Medical Americas, INC. | $17.54 | 2025 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxime Gedeon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.